ADENURIC Tablets - Medsafe
ADENURIC® Tablets febuxostat 80 mg and 120 mg tablets Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ADENURIC® Tablets. It does not contain all the available information.
Download ADENURIC Tablets - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
common when ZURAMPIC was given alone. - …
irwdpi.com2.3 Gout Flares Gout flares may occur after initiation of urate lowering therapy, including ZURAMPIC, due to changing serum uric acid levels …
INDICATIVE LIST of APIs - GLOPEC
www.glopec.com10 Waterloo Court, Thornhill, Ontario, Canada L3t 6l9 Tel: (905) 771-6695 Fax: (905) 771-6696 E-mail: Mail@glopec.com 10/2010May 2011 01 INDICATIVE LIST of APIs
Azathioprine (non-transplant indications) - IPNSM
www.ipnsm.hscni.netAzathioprine adult (non-transplant indications) June 2017 Page 1 of 3 Using a printed guideline? Always check you are using the most up to date version.
優力康 EURICON - mmh.org.tw
www.mmh.org.tw1. ？ 臨床表現 痛風是因為血中尿酸過高，尿酸鹽晶體沈積於組織或關節腔 內所造成的各種症狀，如關節痛、腫脹及變形。
CLINICAL GUIDELINES FOR TRANSPLANT …
www.transplant.bc.caD RUG I NTERACTIONS. Xanthine oxidase inhibitors (allopurinol and febuxostat (Uloric ®) : Azathioprine is metabolized by xanthine …
高尿酸血症的全身性影響及最新治療建議
www.tsim.org.tw內科學誌 2018：29：1-7 高尿酸血症的全身性影響及最新治療建議 陳得源1-3 余光輝4 謝祖怡5,6 郭美娟7,8 李奕德9,10 許百豐10,11 1中國醫藥大學附設醫院 風濕免疫中心 2中國醫藥大學 醫學系 3國立中興大學轉譯醫學博士學位學程及榮興轉譯醫學研究中心